CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Wednesday reported first-quarter net income of $32.7 million.
On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of $3.75. Losses, adjusted for non-recurring gains, came to $2.24 per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
